CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The NANOBEAT project aims to develop CardioINK, a new medical device designed to restore cardiac conductivity in patients suffering from arrhythmias like Atrial Fibrillation and Left Bundle Branch Blocks. Utilizing a composite biomaterial, CardioINK is delivered to damaged heart tissue to improve signaling and reduce h…
The NANOBEAT consortium is focused on addressing the significant issue of impaired cardiac conductivity and its associated cardiac arrhythmias in the European Union.
These conditions affect around 13-22 million people in the European Union alone.Two of the most important arrhythmias in this context are Atrial Fibrillation (AF) and Left Bundle Branch Blocks (LBBB The debilitating consequences of LBBB and AF include stroke, HF, and death and also contribute greater than 2.6% of the annual healthca…
UNIVERSITATSKLINIKUM HEIDELBERG
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Netherlands, Maastricht
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: No
Ireland, Galway
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 sectors.
Guests see up to 5 keywords.
